Endo Loses Bid to Block Sales of Generic Painkiller

The agency’s decision on generic Opana ER came just weeks after it reached the opposite conclusion in the case of another frequently abused painkiller, OxyContin.    

Source: NYT Health - May 11, 2013 Category: Consumer Health News Authors: By KATIE THOMAS Tags: Pain-Relieving Drugs Drugs (Pharmaceuticals) Opana ER Food and Drug Administration Endo Health Solutions OxyContin (Drug) Generic Brands and Products Source Type: news